Califf: More Learning Necessary During Generic Drug Lifecycle
The US FDA commissioner called for enhancements to postmarketing data collection and analysis for generic drugs.
You may also be interested in...
Technological and logistical challenges have forced agency staff to triage document and interview requests to focus on the most important issues when conducting remote regulatory assessments and in-person inspections, an FDA official told a conference of international regulators.
President Biden’s budget request would add $1.63bn in mandatory funding to the FDA budget in FY 2023.
Reports of bent needles and injector failures also raise questions about the FDA’s complex product approval process.